Developer docs
API playgroundTry for free, no card

Search company profiles

Flinn

Full company profile

uuid0000p5x

Namestring
Flinn
Legal namestring
1BillionLives GmbH
Websiteurl
flinn.ai
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Flinn (legally 1BillionLives GmbH) is an AI-driven SaaS platform that automates regulatory and quality compliance processes for medical device manufacturers (MedTech) and pharmaceutical companies operating under EU MDR/IVDR and adjacent regulatory regimes. Founded in Vienna in 2022 by former N26 employees, the company sells a unified platform with five core modules — Safety Database Monitoring, Literature Evaluation, Regulatory Monitoring, Complaint Handling, and Vigilance — built on NLP, machine learning, and large language models that are fine-tuned on curated medical corpora and validated under IEC 62304 and ISO 13485. Flinn 3.0 (Nov 2025) added Clinical Writing, Citation management, and a Literature Library, and integrations with Mira.Digital (literature procurement) and Siemens Polarion (via avasis) extend the platform into adjacent enterprise systems.

The company serves a vertically segmented customer base spanning small and medium MedTech manufacturers (5–100 Technical Files) up through large enterprises with thousands of Technical Files, including named customers such as Erbe Elektromedizin, Skan AG, and Medi GmbH across 14+ countries in Europe and North America. Pricing is quote-based annual subscription, tiered by portfolio size and module selection, with a free demo / evaluation period reducing sales friction for smaller customers. Distribution is direct enterprise field sales supplemented by inside sales for mid-market and self-serve evaluation for smaller accounts, supported by a strategic advisor network of former executives from Siemens Healthineers, ResMed, Smith & Nephew, and DentsplySirona.

Flinn has raised approximately $30 million cumulatively across a December 2022 pre-seed (€1.8M, Speedinvest and SquareOne), a September 2024 seed (€10M, Cherry Ventures led), and a February 2026 Series A ($20M, HV Capital led with Bertelsmann Healthcare Investments and existing investors participating). The Series A is explicitly directed at US market entry and lifecycle expansion. The company operates from three offices (Vienna HQ, Berlin, Paris) with a headcount in the 11–50 band and is led by co-founders Bastian Krapinger-Rüther, Hasib Samad, and Markus Müller.

Short descriptiontext

Flinn is an AI-powered SaaS platform that automates regulatory and quality compliance workflows for medical device manufacturers and pharmaceutical companies, serving over 100 MedTech customers across 14+ countries with modules for safety database monitoring, literature evaluation, regulatory monitoring, and complaint handling.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVienna, Austria
HQ citystring
Vienna
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device compliance, regulatory automation software, clinical evaluation software, post-market surveillance, MedTech AI platform
Industry3 codes
1Pharmacovigilance & Drug Safety Software
CodeHLAGAJAKPrimaryYes
2Regulatory Affairs & Submissions FSP
CodeHLAGAOADPrimaryNo
3Healthcare Outcomes & Real-World Evidence (RWE) Analytics
CodeBPAHALANPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
MedTech Regulatory Compliance Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription
TypeSubscription Recurring
Description

Cloud-based software subscription model providing access to the Flinn compliance platform, with modules for literature evaluation, safety database monitoring, regulatory monitoring, complaint handling, and vigilance management. Pricing is likely tiered based on portfolio size and number of modules.

flinn.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Enterprise tier for large MedTech manufacturers
ModelSubscriptionBilling cadenceAnnual
Notes

Enterprise pricing based on portfolio size, number of Technical Files, and modules selected. Targets companies with thousands of Tech Files.

flinn.ai
2SME/Mid-market tier
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing for small to medium enterprises managing portfolios of 5-100 Technical Files. Lower entry point than enterprise.

flinn.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Flinn provides an AI-driven SaaS platform that automates regulatory and quality processes for medical device (MedTech) and pharmaceutical manufacturers. Its modular suite covers safety database monitoring, literature evaluation, regulatory change monitoring, complaint handling, and vigilance management, with full validation documentation compliant to IEC 62304, ISO 13485, ISO 27001, EU AI Act, and FDA 21 CFR Part 11. The platform serves over 100 MedTech leaders across 14 countries, processing 40+ million publications and 20+ million incident reports.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Complete vigilance process >80% faster than traditional methods
+5 more records
Product overview1 text field

Flinn is an AI-driven platform for automating regulatory and quality processes in MedTech and Pharma. The platform follows a unified architecture with a core AI engine supporting multiple integrated modules: Safety Database Monitoring (vigilance), Literature Evaluation, Regulatory Monitoring, Complaint Handling, and a Vigilance Module. Flinn 3.0 introduced Clinical Writing, Citation, and Literature Library as sub-features. The platform automates workflows across the entire medical product lifecycle including post-market surveillance, literature reviews, regulatory compliance, and complaint management. Additional capabilities include a Word Plugin for document generation and API integrations with third-party systems like Polarion.

Product and service6 records
1Safety Database Monitoring
CategoryVigilance / Post-Market Surveillance
Description

AI-powered module that automates adverse event and safety database monitoring across 15+ global databases including FDA MAUDE, BfArM, and SwissMedic, with real-time vigilance surveillance, smart grouping of reports, automated de-duplication, and 1-click audit-ready report generation. Built for MedTech and pharmaceutical manufacturers under MDR/IVDR.

2Literature Evaluation
CategoryClinical Evaluation / Literature Review
Description

AI-assisted literature search and screening module for systematic reviews, state-of-the-art searches, and PMCF/PMPF literature evaluation. Features multi-database search across 40+ million publications, human study detection with 99% precision, and integration with Mira.Digital for embedded literature purchasing.

3Regulatory Monitoring
CategoryRegulatory Intelligence
Description

Module for monitoring and analyzing global regulatory changes and standards updates. Tracks changes to MDR, IVDR, FDA requirements, and other standards, with delta and impact analysis for regulatory compliance.

4Complaint Handling
CategoryQuality Management / Complaint Management
Description

Module for managing complaint data intake, evaluation, and processing. Supports structured complaint workflows, intelligent categorization, and integration with risk management systems for MedTech compliance.

5Vigilance Module
CategoryPost-Market Surveillance
Description

Comprehensive post-market surveillance module supporting PMS/PSUR reporting, PMCF/PMPF follow-up activities, and safety signal detection. Features automated monitoring, evaluation workflows, and audit-ready documentation with >80% faster vigilance processes versus traditional methods.

6Flinn Word Plugin
CategoryDocumentation / Reporting Add-on
Description

Microsoft Word integration enabling direct literature report generation, citation management, and document writing within Word for regulatory and clinical writing teams.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2025-08-14
Description

API integration partnership connecting Flinn with Siemens Polarion for streamlined MedTech regulatory workflows, enabling data exchange between quality management and regulatory compliance systems.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-04-30
Description

Integration partnership for literature procurement and license handling. Mira provides embedded purchasing and license management for scientific publications within Flinn's Literature Module, covering 99.9% of scientific publications worldwide with validated licensing compliance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership providing MDR-compliant support in risk management, clinical evaluation, and regulatory affairs. qtec complements Flinn's platform with specialized consulting services throughout the medical device product lifecycle.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MedTech-focused quality management and regulatory compliance SaaS offering eQMS, CAPA, design controls, and document management — directly competes with Flinn's regulatory/quality automation platform for medical device manufacturers.

TypeDirect peer
Description

Established QMS and regulatory compliance platform purpose-built for life sciences and MedTech, offering validated software for document control, training, and quality processes — overlaps with Flinn's validated compliance modules.

TypeDirect peer
Description

Regulatory information management platform purpose-built for medical device companies, covering submissions, registrations, standards, and global regulatory intelligence — closely mirrors Flinn's regulatory monitoring and submissions support.

TypeDirect peer
Description

AI-enabled QMS solution for MedTech and pharma covering complaints, CAPA, audits, and training — direct competitor in the AI-powered MedTech compliance category.

TypeDirect peer
Description

Digital validation lifecycle management SaaS for life sciences, used for equipment, computer system, and process validation — comparable to Flinn on the regulated validation/documentation layer of MedTech workflows.

TypeDirect peer
Description

Life sciences regulatory technology platform covering regulatory information management, pharmacovigilance, and safety — overlaps with Flinn's vigilance and regulatory monitoring modules for pharma and MedTech.

TypeBroad incumbent
Description

Large incumbent cloud software provider for life sciences with Vault RIM, Vault QMS, and safety modules — broader portfolio than Flinn but competes on regulatory document and quality management for MedTech/pharma.

TypeBroad incumbent
Description

Global CRO and life sciences technology provider with regulatory affairs, safety/pharmacovigilance, and RWE services — competes indirectly through its tech-enabled regulatory and safety offerings for MedTech manufacturers.

TypeDirect peer
Description

Regulatory document validation and text-comparison software widely used in pharma/MedTech regulatory affairs — comparable to Flinn on regulatory submission accuracy and document proofreading use cases.

TypeDirect peer
Description

Regulated quality management software for life sciences including complaints, CAPA, change control, and audits — overlaps with Flinn's complaint handling and regulatory workflow automation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Flinn

MedTech Regulatory Compliance Softwareflinn.ai

Flinn is an AI-powered SaaS platform that automates regulatory and quality compliance workflows for medical device manufacturers and pharmaceutical companies, serving over 100 MedTech customers across 14+ countries with modules for safety database monitoring, literature evaluation, regulatory monitoring, and complaint handling.

What Flinn does

Flinn (legally 1BillionLives GmbH) is an AI-driven SaaS platform that automates regulatory and quality compliance processes for medical device manufacturers (MedTech) and pharmaceutical companies operating under EU MDR/IVDR and adjacent regulatory regimes. Founded in Vienna in 2022 by former N26 employees, the company sells a unified platform with five core modules — Safety Database Monitoring, Literature Evaluation, Regulatory Monitoring, Complaint Handling, and Vigilance — built on NLP, machine learning, and large language models that are fine-tuned on curated medical corpora and validated under IEC 62304 and ISO 13485. Flinn 3.0 (Nov 2025) added Clinical Writing, Citation management, and a Literature Library, and integrations with Mira.Digital (literature procurement) and Siemens Polarion (via avasis) extend the platform into adjacent enterprise systems.

The company serves a vertically segmented customer base spanning small and medium MedTech manufacturers (5–100 Technical Files) up through large enterprises with thousands of Technical Files, including named customers such as Erbe Elektromedizin, Skan AG, and Medi GmbH across 14+ countries in Europe and North America. Pricing is quote-based annual subscription, tiered by portfolio size and module selection, with a free demo / evaluation period reducing sales friction for smaller customers. Distribution is direct enterprise field sales supplemented by inside sales for mid-market and self-serve evaluation for smaller accounts, supported by a strategic advisor network of former executives from Siemens Healthineers, ResMed, Smith & Nephew, and DentsplySirona.

Flinn has raised approximately $30 million cumulatively across a December 2022 pre-seed (€1.8M, Speedinvest and SquareOne), a September 2024 seed (€10M, Cherry Ventures led), and a February 2026 Series A ($20M, HV Capital led with Bertelsmann Healthcare Investments and existing investors participating). The Series A is explicitly directed at US market entry and lifecycle expansion. The company operates from three offices (Vienna HQ, Berlin, Paris) with a headcount in the 11–50 band and is led by co-founders Bastian Krapinger-Rüther, Hasib Samad, and Markus Müller.

Flinn firmographics

Firmographics
Name
Flinn
Legal name
1BillionLives GmbH
Website
https://flinn.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Flinn is an AI-powered SaaS platform that automates regulatory and quality compliance workflows for medical device manufacturers and pharmaceutical companies, serving over 100 MedTech customers across 14+ countries with modules for safety database monitoring, literature evaluation, regulatory monitoring, and complaint handling.
Ownership category
akta.pro rank

Flinn industry classification

Industry
Product category
MedTech Regulatory Compliance Software
NAICS
Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Pharmacovigilance & Drug Safety Software (HLAGAJAK)
akta.pro secondary industries
Regulatory Affairs & Submissions FSP (HLAGAOAD), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

  • Medical device compliance
  • Regulatory automation software
  • Clinical evaluation software
  • Post-market surveillance
  • MedTech AI platform

Where Flinn is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
Austria
HQ region
Europe

Offices3 records

Markets served

Flinn business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscription: Cloud-based software subscription model providing access to the Flinn compliance platform, with modules for literature evaluation, safety database monitoring, regulatory monitoring, complaint handling, and vigilance management. Pricing is likely tiered based on portfolio size and number of modules.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise tier for large MedTech manufacturers
SubscriptionAnnualSME/Mid-market tier

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Flinn product offering

Product offering

Core offering

Flinn provides an AI-driven SaaS platform that automates regulatory and quality processes for medical device (MedTech) and pharmaceutical manufacturers. Its modular suite covers safety database monitoring, literature evaluation, regulatory change monitoring, complaint handling, and vigilance management, with full validation documentation compliant to IEC 62304, ISO 13485, ISO 27001, EU AI Act, and FDA 21 CFR Part 11. The platform serves over 100 MedTech leaders across 14 countries, processing 40+ million publications and 20+ million incident reports.

Product overview

Flinn is an AI-driven platform for automating regulatory and quality processes in MedTech and Pharma. The platform follows a unified architecture with a core AI engine supporting multiple integrated modules: Safety Database Monitoring (vigilance), Literature Evaluation, Regulatory Monitoring, Complaint Handling, and a Vigilance Module. Flinn 3.0 introduced Clinical Writing, Citation, and Literature Library as sub-features. The platform automates workflows across the entire medical product lifecycle including post-market surveillance, literature reviews, regulatory compliance, and complaint management. Additional capabilities include a Word Plugin for document generation and API integrations with third-party systems like Polarion.

Differentiator

Problem solved

Functional benefit

Products and services

  • Safety Database Monitoring AI-powered module that automates adverse event and safety database monitoring across 15+ global databases including FDA MAUDE, BfArM, and SwissMedic, with real-time vigilance surveillance, smart grouping of reports, automated de-duplication, and 1-click audit-ready report generation. Built for MedTech and pharmaceutical manufacturers under MDR/IVDR.
  • Literature Evaluation AI-assisted literature search and screening module for systematic reviews, state-of-the-art searches, and PMCF/PMPF literature evaluation. Features multi-database search across 40+ million publications, human study detection with 99% precision, and integration with Mira.Digital for embedded literature purchasing.
  • Regulatory Monitoring Module for monitoring and analyzing global regulatory changes and standards updates. Tracks changes to MDR, IVDR, FDA requirements, and other standards, with delta and impact analysis for regulatory compliance.
  • Complaint Handling Module for managing complaint data intake, evaluation, and processing. Supports structured complaint workflows, intelligent categorization, and integration with risk management systems for MedTech compliance.
  • Vigilance Module Comprehensive post-market surveillance module supporting PMS/PSUR reporting, PMCF/PMPF follow-up activities, and safety signal detection. Features automated monitoring, evaluation workflows, and audit-ready documentation with >80% faster vigilance processes versus traditional methods.
  • Flinn Word Plugin Microsoft Word integration enabling direct literature report generation, citation management, and document writing within Word for regulatory and clinical writing teams.

Quantifiable outcome

  • Complete vigilance process >80% faster than traditional methods
  • +5 more outcomes

Companies that use Flinn

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Flinn technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature8 records

Flinn partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered supporting and core.

  • avasis solutions GmbHsupportingTechnology or Integration · 14 August 2025API integration partnership connecting Flinn with Siemens Polarion for streamlined MedTech regulatory workflows, enabling data exchange between quality management and regulatory compliance systems.
  • MIRA.Digital GmbHcoreTechnology or Integration · 30 April 2025Integration partnership for literature procurement and license handling. Mira provides embedded purchasing and license management for scientific publications within Flinn's Literature Module, covering 99.9% of scientific publications worldwide with validated licensing compliance.
  • qtec Services GmbHcoreStrategic or Co-development PartnerStrategic partnership providing MDR-compliant support in risk management, clinical evaluation, and regulatory affairs. qtec complements Flinn's platform with specialized consulting services throughout the medical device product lifecycle.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Flinn competitors and assessment

Company assessment

Direct peers

  • Greenlight Guru: MedTech-focused quality management and regulatory compliance SaaS offering eQMS, CAPA, design controls, and document management — directly competes with Flinn's regulatory/quality automation platform for medical device manufacturers.
  • MasterControl: Established QMS and regulatory compliance platform purpose-built for life sciences and MedTech, offering validated software for document control, training, and quality processes — overlaps with Flinn's validated compliance modules.
  • Rimsys: Regulatory information management platform purpose-built for medical device companies, covering submissions, registrations, standards, and global regulatory intelligence — closely mirrors Flinn's regulatory monitoring and submissions support.
  • Dot Compliance: AI-enabled QMS solution for MedTech and pharma covering complaints, CAPA, audits, and training — direct competitor in the AI-powered MedTech compliance category.
  • Kneat: Digital validation lifecycle management SaaS for life sciences, used for equipment, computer system, and process validation — comparable to Flinn on the regulated validation/documentation layer of MedTech workflows.
  • ArisGlobal: Life sciences regulatory technology platform covering regulatory information management, pharmacovigilance, and safety — overlaps with Flinn's vigilance and regulatory monitoring modules for pharma and MedTech.
  • Schlafender Hase: Regulatory document validation and text-comparison software widely used in pharma/MedTech regulatory affairs — comparable to Flinn on regulatory submission accuracy and document proofreading use cases.
  • AssurX: Regulated quality management software for life sciences including complaints, CAPA, change control, and audits — overlaps with Flinn's complaint handling and regulatory workflow automation.

Broad incumbents

  • Veeva Systems: Large incumbent cloud software provider for life sciences with Vault RIM, Vault QMS, and safety modules — broader portfolio than Flinn but competes on regulatory document and quality management for MedTech/pharma.
  • IQVIA: Global CRO and life sciences technology provider with regulatory affairs, safety/pharmacovigilance, and RWE services — competes indirectly through its tech-enabled regulatory and safety offerings for MedTech manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Flinn social profiles

Digital presence

Flinn compliance and trust

Trust signal

Compliance7 records

Flinn financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Flinn leadership team

Management profile

Number of profiles

Profiles5 records

Flinn funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Flinn M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Flinn

What does Flinn do?

Flinn provides an AI-driven SaaS platform that automates regulatory and quality processes for medical device (MedTech) and pharmaceutical manufacturers. Its modular suite covers safety database monitoring, literature evaluation, regulatory change monitoring, complaint handling, and vigilance management, with full validation documentation compliant to IEC 62304, ISO 13485, ISO 27001, EU AI Act, and FDA 21 CFR Part 11. The platform serves over 100 MedTech leaders across 14 countries, processing 40+ million publications and 20+ million incident reports.

Is Flinn a public or private company?

Flinn is a private company. It is classified as venture growth investor backed and is currently operating.

When was Flinn founded?

Flinn was founded in 2022. It employs 11 to 50 people.

Where is Flinn based?

Flinn is headquartered in Vienna, Austria, in the Europe region.

How does Flinn make money?

One revenue line is on record: saaS Subscription.

Who are Flinn's main competitors?

Direct peers on record are Greenlight Guru, MasterControl, Rimsys, Dot Compliance, Kneat, ArisGlobal, Schlafender Hase and AssurX. Broad incumbents are Veeva Systems and IQVIA.

Does Flinn have an API?

Yes. Flinn offers an API integration that connects with Polarion via avasis solutions GmbH partnership. This API integration enables interoperability between Flinn's regulatory and quality management platform and Polarion (a product lifecycle management software) for MedTech workflows.

What industry is Flinn in?

Flinn's product category is MedTech Regulatory Compliance Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGAOAD, Regulatory Affairs & Submissions FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
deutsche-startups.de+++ Voyager Ventures +++ Soonicorn +++ Black Semiconductor +++ Flinn +++The article provides a daily startup news roundup covering several key developments, including Black Semiconductor receiving significant funding from Porsche Ventures and German government bodies, and Flinn securing investment to expand into the US market. Additionally, US-based Voyager Ventures opened a new office in Munich to target investments in energy and industrial technology, while SAP made an investment in HealthTech Avelios Medical.CybernewscentreAI Startup Update: Vienna's Flinn.ai Secures $20M for MedTech Compliance AutomationVienna-based AI startup Flinn.ai has secured $20 million in a Series A funding round led by HV Capital, with participation from BHI – Bertelsmann Healthcare Investments and existing investors Cherry Ventures, Speedinvest, and SquareOne. The company develops an AI platform that automates quality and regulatory compliance processes for medical device and pharmaceutical manufacturers, helping them navigate frameworks like Europe's MDR and IVDR. The funding will be used to expand the platform across the product lifecycle and support entry into the US market, bringing total capital raised to approximately $30 million.Pulse 2.0Flinn: $20 Million Raised To Automate The Product Lifecycle In Medtech And Pharma With AIFlinn, a Vienna-based AI-powered regulatory and quality automation software company serving MedTech and Pharma, has raised $20 million in funding led by HV Capital with participation from BHI (Bertelsmann Healthcare Investments), Cherry Ventures, Speedinvest, and SquareOne. The funding will support expansion of the platform beyond regulatory and post-market functions to cover research and development, commercial, and post-market processes across the full product lifecycle. The company also plans to extend its footprint from Europe into the US market as it targets global demand for scalable, compliant healthcare innovation solutions.VentureburnFlinn.ai Raises $20M in Series A Funding Round ExpansionFlinn.ai, a Vienna-based AI startup, raised $20 million in Series A funding led by HV Capital, with participation from Bertelsmann Healthcare Investments and existing investors Cherry Ventures, Speedinvest, and SquareOne. The funding will be used to expand the company's AI platform for medtech and pharmaceutical companies across the entire product lifecycle and to enter the U.S. market. The platform automates regulatory compliance, quality management, and safety monitoring tasks using machine learning and natural language processing.BeinsureFlinn raises $20 mn to automate medtech compliance workflowsVienna-based startup Flinn secured $20 million in follow-on funding, led by HV Capital with participation from BHI – Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, and SquareOne. The company, founded in 2022, will use the capital to expand its AI-driven regulatory and quality automation platform for medtech manufacturers and support international expansion across Europe and into the United States. The platform automates documentation, data analysis, and reporting tasks across the medical product lifecycle, replacing manual processes with structured digital workflows.deutsche-startups.deFlinn sammelt 20 Millionen einFlinn, a Vienna-based startup founded in 2022, raised €20 million in a funding round led by HV Capital and BHI (Bertelsmann Healthcare Investments), with participation from existing investors Cherry Ventures, Speedinvest, and SquareOne. The company automates compliance processes for medical device manufacturers and pharmaceutical companies, with plans to expand its platform across the entire product lifecycle in MedTech and Pharma. Additional deals include Ferrero investing a double-digit million sum in Neoh (a Vienna-based low-calorie chocolate brand) and Swedish workwear manufacturer Blåkläder acquiring an 85% majority stake in Cologne laundry service provider WaschMal.Trending TopicsVienna’s Flinn Raises €17M Series A to Automate MedTech and Pharma ComplianceVienna-based scale-up Flinn completed a €17 million Series A funding round led by HV Capital, with participation from BHI (Bertelsmann Healthcare Investments) and existing investors Cherry Ventures, Speedinvest, and SquareOne. The company develops AI-powered software to automate regulatory and quality processes for medical device and pharmaceutical companies, addressing complex compliance requirements such as the EU's Medical Device Regulation. Flinn plans to use the funding to expand its platform across the entire product lifecycle and prepare for international expansion into the US market.Tech.euFlinn secures $20M to develop AI tools for product lifecycle management in medtech and pharmaVienna-based Flinn, an AI-powered software provider for automating regulatory and quality processes in medtech and pharma, has raised $20 million in additional funding. The round was led by HV Capital with participation from BHI – Bertelsmann Healthcare Investments and existing investors Cherry Ventures, Speedinvest, and SquareOne. The company plans to use the funding to expand its platform across earlier development stages and commercial processes, while supporting international growth including entry into the US market.StartbaseFlinn secures 20 million US dollars for AI-supported automation in MedTech and PharmaFlinn, a pan-European AI automation company for regulatory and quality processes in MedTech and Pharma, has secured 20 million US dollars in a new financing round. The round was led by HV Capital with participation from BHI (Bertelsmann Healthcare Investments) and existing investors Cherry Ventures, Speedinvest and SquareOne. The capital will be used to expand the platform across the entire product lifecycle and accelerate expansion into Europe and the USA.VestbeeAustria's Flinn raises $20M to expand AI platform for medtech and pharma complianceVienna-based startup Flinn.ai has raised $20 million in Series A funding led by HV Capital, with participation from BHI – Bertelsmann Healthcare Investments and existing investors Cherry Ventures, Speedinvest, and SquareOne Venture Capital, to expand its AI-driven compliance platform for medtech and pharma companies. The platform automates regulatory and quality compliance processes including post-market surveillance, literature evaluation, and complaint handling for medical device manufacturers, helping them meet MDR and IVDR requirements. Founded in 2022, the company will use the funding to expand across more stages of the medical product lifecycle, automate additional workflows, and support international growth including entry into the US market.